Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Metastatic castration-resistant prostate cancer
0.060 Biomarker disease BEFREE We developed a 3-color FISH assay to detect genomic deletions of BRCA2 and RB1 in prostate cancer cells and patient-derived mCRPC organoids. 31796516 2019
Metastatic castration-resistant prostate cancer
0.060 GeneticVariation disease BEFREE Our study provides evidence that mCRPC with BRCA2 germline mutations could response to PARP inhibitor, which improves patient's outcome. 30333000 2018
Metastatic castration-resistant prostate cancer
0.060 Biomarker disease BEFREE An estimated one-fifth or more of metastatic castration-resistant prostate cancer (mCRPC) harbor defects in genes involved in DNA repair pathway (e.g., BRCA2, BRCA1, and others). 29555412 2018
Metastatic castration-resistant prostate cancer
0.060 PosttranslationalModification disease BEFREE Commentary on "Biallelic inactivation of BRCA2 in platinum-sensitive metastatic castration-resistant prostate cancer". Cheng HH, Pritchard CC, Boyd T, Nelson PS, Montgomery B. Eur Urol. Jun 2016;69(6):992-5. 28623073 2017
Metastatic castration-resistant prostate cancer
0.060 GeneticVariation disease BEFREE BRCA2-mutant PCa shows genomic and epigenomic dysregulation of the MED12L/MED12 axis, which is frequently dysregulated in metastatic castration-resistant prostate cancer (mCRPC). 28067867 2017
Metastatic castration-resistant prostate cancer
0.060 AlteredExpression disease BEFREE Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer. 26724258 2016